BELLUS Health Reports Results for Second Quarter Ended June 30, 2011
8/10/2011 10:41:32 AM
More...
|
BELLUS Health Exercises Option to Terminate Lease
1/14/2011 12:10:37 PM
More...
|
BELLUS Health and Celtic Therapeutics Enter Agreement Worth $20 Million for Drug candidate KIACTA(TM)
4/30/2010 1:08:14 PM
More...
|
Geller Biopharm Successfully Advises BELLUS Health in Its KIACTA(TM) Transaction With Celtic Therapeutics
4/30/2010 10:38:16 AM
More...
|
Roberto Bellini Appointed President and CEO of BELLUS Health
12/15/2009 6:44:10 AM
More...
|
BELLUS Health Reports Results for First Half of Fiscal 2009
8/12/2009 8:49:25 AM
More...
|
BELLUS Health Announces $12 Million Rights Offering To Common Shareholders
7/8/2009 9:16:37 AM
More...
|
BELLUS Health Announces Chief Financial Officer to Depart Effective May 22, 2009
4/27/2009 9:51:56 AM
More...
|
BELLUS Health Announces Completion of First Tranche of Financing
4/17/2009 7:03:30 AM
More...
|
BELLUS Health Provides an Update on the Financing and the Restructuring of Existing Notes
4/9/2009 11:11:24 AM
More...
|
|